Impact of lotilaner ophthalmic solution 0.25% on disease severity in patients with Demodex blepharitis and meibomian gland disease

PurposeTo evaluate the impact of lotilaner ophthalmic solution, 0.25%, compared to vehicle, on disease severity in patients with Demodex blepharitis and meibomian gland disease.MethodsThis post-hoc analysis pooled data from two prospective, randomized, double-masked studies evaluating lotilaner opht...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Bridgitte Shen Lee, Elizabeth Yeu, Kavita Dhamdhere, Eric D. Donnenfeld
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2026-01-01
Sarja:	Frontiers in Medicine
Aiheet:	Demodex blepharitis with meibomian gland disease lotilaner meibomian gland disease severity meibomian gland secretion score ocular surface disease
Linkit:	https://www.frontiersin.org/articles/10.3389/fmed.2026.1719825/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!